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Introduction {#sec001}
============

Osteoporosis is a common disease characterized by low bone mineral density (BMD) and microarchitectural deterioration of bone tissue leading to increased risk of low-trauma osteoporotic fractures. Hip fractures are the most common and severe form of osteoporotic fractures associated with high mortality and tremendous health care costs \[[@pone.0117102.ref001]\]. The incidence of hip fractures continues to increase rapidly in developing countries \[[@pone.0117102.ref002]\]. One third of the world's hip fractures now occur in Asia, mostly in China, and this rate will rise to 52% by 2050 \[[@pone.0117102.ref003]\]. Clinically, osteoporosis is defined through the measurement of BMD, which is the single best predictor of osteoporotic fractures \[[@pone.0117102.ref004],[@pone.0117102.ref005]\].

Genetic factors have important influence on BMD and osteoporotic fractures, with heritability estimates of 0.6--0.8 for BMD \[[@pone.0117102.ref006]\] and \~0.5 for osteoporotic fractures \[[@pone.0117102.ref007]\]. However, the genetic variants actually involved remain largely unknown. In recent years, a number of genome-wide association studies (GWASs) on BMD have been successfully performed and more than 60 genome-wide significant loci have been reported \[[@pone.0117102.ref008]\]. Nevertheless, all the identified loci so far have modest effects on BMD and account for only a small proportion of the variance in liability to osteoporosis, suggesting that many more associated loci remain to be discovered.

*DDR2* gene (discoidin domain receptor 2) is located in chromosome 1q23.3 and encodes a member of the receptor tyrosine kinase (RTK) family that binds collagens and regulates cellular responses to the extracellular matrix \[[@pone.0117102.ref009]\]. DDR2 is demonstrated to be expressed in osteocytes, osteoblastic cells in subchondral bone, bone lining cells, tibia and cartilage \[[@pone.0117102.ref010],[@pone.0117102.ref011],[@pone.0117102.ref012]\]. In vivo studies provide functional evidence that DDR2 is required for normal bone development. Knockout of *DDR2* in mice leads to dwarfism, manifested by shortening of long bones \[[@pone.0117102.ref013],[@pone.0117102.ref014]\]. In humans, mutations in *DDR2* gene are responsible for spondylometaepiphyseal dysplasia, which is manifested by short limbs with abnormal calcification \[[@pone.0117102.ref015]\]. Moreover, in vitro studies have shown that *DDR2* plays an essential role in osteoblast differentiation and chondrocyte maturation via a signaling pathway that involves MAP kinases and leads to the activation of the transcription factor RUNX2 \[[@pone.0117102.ref011],[@pone.0117102.ref016]\]. Given the biological function of *DDR2* involved in bone, it is reasonable to hypothesize that *DDR2* may influence BMD and could be a new candidate gene for osteoporosis risk estimation, but the genetic variations actually leading to the association remain to be elucidated. Therefore, the aim of this study was to investigate the role of genetic variations of *DDR2* in BMD and fracture risk. Our study was performed in three samples from two ethnicities, including two Chinese Han populations and a US white population, in order to see whether the variants identified are common or ethnic-specific.

Materials and Methods {#sec002}
=====================

Subjects {#sec003}
--------

The study was approved by the Research Administration of School of Life Science and Technology at Xi'an Jiaotong University and Institutional Review Board at Creighton University and University of Missouri-Kansas City. Signed informed consent documents were obtained from all study participants before entering the study. The basic characteristics of the study samples are summarized in [Table 1](#pone.0117102.t001){ref-type="table"}, with additional descriptions below.

10.1371/journal.pone.0117102.t001

###### Basic characteristics of the study subjects.

![](pone.0117102.t001){#pone.0117102.t001g}

  Trait               Chinese BMD sample   Chinese fracture sample   Caucasian sample   
  ------------------- -------------------- ------------------------- ------------------ ---------------
  Number              1,300                350                       350                2,286
  Male/Female         600/700              124/226                   173/177            558/1,727
  Age (years)         33.42 (11.32)        69.35 (7.41)              69.54 (6.09)       51.37 (13.76)
  Weight (kg)         59.63 (10.41)        59.15 (12.05)             59.61 (10.84)      75.27 (17.54)
  Height (cm)         163.94 (8.11)        162.84 (8.31)             159.41 (9.20)      166.35 (8.47)
  Hip BMD (g/cm^2^)   0.92 (0.13)          −                         −                  0.97 (0.18)

Note: Data are shown as mean (standard deviation, SD).

**Chinese samples**. We have two Chinese samples, one is BMD sample from a population-based cohort, and the other is fracture sample from a case-control cohort. All the subjects were unrelated northern Chinese Han adults living in the city of Xi'an and its neighboring areas. The BMD sample comprised 1,300 unrelated Chinese Han subjects. The inclusion and exclusion criteria have been detailed in our previous publication \[[@pone.0117102.ref017]\]. BMD (g/cm^2^) values at total hip were measured using Hologic 4500W machines (Hologic Inc., Bedford, MA, USA). The coefficient of variation (CV) value of the hip BMD was approximately 1.33%.

The fracture sample consisted of 350 cases with osteoporotic hip fractures and 350 elderly healthy controls. Hip fracture was diagnosed by orthopedic surgeons/radiologists according to radiological reports and X-rays. Healthy control subjects were selected from our established database as a ratio of 1:1 to cases and geography-matched. The inclusion and exclusion criteria for cases and controls have been described in detail in our earlier publication \[[@pone.0117102.ref017]\].

**Caucasian sample**. The Caucasian sample came from a population-based cohort, which consisted of 2,286 unrelated adults. All of the subjects were US Caucasians of Northern European origin living in Midwestern area. The sample description has been detailed in our previous study \[[@pone.0117102.ref018]\]. BMD values at hip were measured using the same model Hologic 4500W machines (Hologic Inc., Bedford, MA, USA) under the same strict protocols used in the Chinese sample. The CV value of the hip BMD was approximately 1.87%.

SNP selection and genotyping {#sec004}
----------------------------

Genomic DNA was extracted from peripheral blood leukocytes using a commercial isolation kit (Gentra systems, Minneapolis, MN, USA) following the protocol of the kit. Selection of SNPs was done on data of the CHB population (Han Chinese in Beijing, China) provided by the HapMap project (Rel28 PhaseII + III, August10, on NCBI B36 assembly, dbSNP b126). We initially selected 30 SNPs in *DDR2* according to the following criteria: (i) minor allele frequency (MAF) \> 0.05 in the CHB (Han Chinese in Beijing, China) population; (ii) an average density of 1 SNP per 5 kb; (iii) tagging SNP information.

For the Chinese BMD sample, SNP genotyping was carried out using MALDI-TOF mass spectrometry on a MassARRAY system (Sequenom, Inc., San Diego, CA) with iPLEX assay. Genotype calling was performed in real time with MassARRAY RT software version 3.0.0.4 and analyzed using the MassARRAY Typer software version 3.4 (Sequenom). Genotyping quality control procedures leading to SNP exclusion were call rate \< 90%, MAF \< 0.05 and *P* \< 0.001 for deviations from Hardy--Weinberg equilibrium (HWE). The average call rate was 98% and the duplicate concordance rate was 99%. Of the 30 SNPs attempted, 28 were genotyped successfully. The basic characteristics of all the qualified SNPs are summarized in [Table 2](#pone.0117102.t002){ref-type="table"}. For the Chinese fracture sample, SNP genotyping was performed using the Affymetrix Human Mapping 500K array set, which has been finished in our previous experiments \[[@pone.0117102.ref017]\]. For the Caucasian sample, SNP genotyping was performed using Genome-Wide Human SNP Array 6.0 (Affymetrix, Santa Clara, CA, USA), which has been detailed before \[[@pone.0117102.ref018]\]. For SNPs missing in the Affymetrix 500K or 6.0 arrays, we imputed genotypes using the IMPUTE program \[[@pone.0117102.ref019]\] to facilitate comparison of associations at the same SNPs. To guarantee the reliability of imputation, all imputed SNPs reached a calling threshold of 0.90, i.e., there was a 90% probability that an imputed genotype is true.

10.1371/journal.pone.0117102.t002

###### Properties of all SNPs in *DDR2* tested in this study.
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  No.   SNP          Physical position   Genic position   Allele 1   Allele 2   MAF
  ----- ------------ ------------------- ---------------- ---------- ---------- -------
  1     rs4518873    162603729           Intron1          C          T          0.372
  2     rs6671267    162608768           Intron1          G          A          0.095
  3     rs10917577   162613975           Intron1          A          G          0.385
  4     rs10799854   162619828           Intron1          C          T          0.113
  5     rs3795641    162625020           Exon2            G          A          0.113
  6     rs10799858   162630279           Intron2          G          A          0.175
  7     rs12044481   162635875           Intron2          A          G          0.261
  8     rs4657221    162642183           Intron2          G          A          0.168
  9     rs7521233    162649471           Intron2          C          T          0.266
  10    rs4657226    162653274           Intron2          G          A          0.388
  11    rs6697469    162658773           Intron2          C          G          0.253
  12    rs7553831    162661011           Intron2          T          G          0.264
  13    rs10737487   162667331           Intron2          G          A          0.407
  14    rs3923572    162671589           Intron2          T          C          0.237
  15    rs10917588   162676191           Intron2          C          T          0.398
  16    rs4559477    162681151           Intron2          T          G          0.365
  17    rs16843872   162686362           Intron2          G          A          0.129
  18    rs1039873    162692668           Intron3          C          G          0.226
  19    rs2805034    162699597           Intron3          A          G          0.229
  20    rs1510310    162703160           Intron3          C          G          0.232
  21    rs2806423    162711989           Intron3          T          A          0.247
  22    rs2684865    162721688           Intron3          T          C          0.222
  23    rs2684866    162726281           Intron7          A          C          0.412
  24    rs10799870   162733123           Intron9          T          C          0.173
  25    rs2298258    162737116           Exon11           G          C          0.389
  26    rs3738807    162741794           Intron12         T          C          0.227
  27    rs1780007    162748025           Intron16         A          C          0.420
  28    rs1779999    162753092           3'UTR            C          T          0.418

Note: MAF, minor allele frequency for allele A1 in the Chinese BMD sample.

Statistical analyses {#sec005}
--------------------

Before association analyses, to correct for potential population stratification that may result in spurious association results, we applied principal component analysis implemented in EIGENSTRAT \[[@pone.0117102.ref020]\] to all available genotypic data in the Chinese fracture and Caucasian samples, retaining the top ten principal components. For the BMD samples, significant parameters (*P* \< 0.05) such as age, sex, height and weight were used as covariates to adjust for the raw BMD values. The distribution of the resulting residuals was tested for normality by Kolmogorov-Smirnov test. The residuals were used for association analyses. Linear regression implemented in PLINK \[[@pone.0117102.ref021]\] was fitted to examine association for each SNP assuming an additive inheritance model. Population haplotypes and their frequencies were inferred using Haploview software \[[@pone.0117102.ref022]\]. Haplotypes with estimated frequencies greater than 5% were included for association analyses by PLINK \[[@pone.0117102.ref021]\]. A raw *P* value of \< 0.05 in our study was considered nominally significant, which was further subjected to Bonferroni correction to account for multiple comparisons. The significance threshold was set at a *P* value of less than 0.0018 for single SNP test (0.05/28 SNPs that were included in the association analyses) and 0.0038 for haplotype analysis (0.05/13 haplotypes that were included in the association analyses). For the validation analyses in the fracture sample, SNPTEST \[[@pone.0117102.ref019]\] was used to test for associations between genotypes and hip fractures. The covariates included age, sex, height, and weight.

Expression quantitative trait locus (eQTL) analysis {#sec006}
---------------------------------------------------

We examined associations between SNPs and mRNA expression levels of the *DDR2* gene, to ascertain whether the SNPs associated with BMD affected expression of their transcript. Gene expression information was obtained from human lymphoblastoid cell lines (LCLs) of 210 unrelated individuals from HapMap populations in the NCBI Gene Expression Omnibus \[[@pone.0117102.ref023],[@pone.0117102.ref024]\]. The sample included 60 white individuals from the CEU (Utah residents with northern and western European ancestry) and 45 Han Chinese individuals. SNP genotype data were derived from the corresponding HapMap Phase III dataset. The linear regression model implemented in PLINK \[[@pone.0117102.ref021]\] was used to determine associations between expression levels and genotypes.

Results {#sec007}
=======

Association of SNPs in *DDR2* with BMD in the Chinese sample {#sec008}
------------------------------------------------------------

The basic characteristics of the study subjects are provided in [Table 1](#pone.0117102.t001){ref-type="table"}. The single SNP association results are summarized in [Table 3](#pone.0117102.t003){ref-type="table"}. For the Chinese sample, there were 18 SNPs showing nominally significant associations with hip BMD (*P* \< 0.05). After Bonferroni correction for multiple testing, 3 SNPs remained significant, which were rs7521233 (*P* = 1.06×10^−4^), rs7553831 (*P* = 1.30×10^−4^), and rs6697469 (*P* = 1.59×10^−3^), separately. Each minor allele of these 3 SNPs was associated with reduced hip BMD values with the effect size (β) of-0.018 (rs7521233-C), −0.018 (rs7553831-T), and-0.015 (rs6697469-C), respectively. All of these 3 SNPs are located at the intron 2 of *DDR2*. We further characterized the linkage disequilibrium (LD) block and haplotypes for *DDR2*. Four blocks in high LD were identified, which ranged in size from 11--60 kb ([Fig. 1A](#pone.0117102.g001){ref-type="fig"}). In these blocks, a total of 20 haplotypes were identified and 13 of them were with frequencies more than 0.05 ([Fig. 1B](#pone.0117102.g001){ref-type="fig"}). [Table 4](#pone.0117102.t004){ref-type="table"} listed the major association results for common haplotypes within each block. All of the 4 blocks showed nominally significant associations. After multiple testing adjustment, 2 haplotypes remained significant, which were haplotypes "CGCT" in block 2 (*P* = 9.54×10^−4^, β = −0.016) and "CACTTACGTAC" in block 4 (*P* = 2.63×10^−3^, β = −0.015). Block 2 included the above 3 significant SNPs (rs7521233, rs7553831, and rs6697469), presenting the consistent results between single SNP and haplotype analyses. As shown in [Fig. 1](#pone.0117102.g001){ref-type="fig"}, these 3 SNPs were in high LD with each other (pairwise LD *r* ^2^ and D' \> 0.9).

![Linkage disequilibrium (LD) blocks and haplotype frequencies for *DDR2* in the Chinese BMD sample.\
(A). LD blocks are marked with triangles. Squares in red indicate strong LD. (B). Haplotypes in the four blocks across *DDR2*. The haplotype frequencies are shown to the right of each haplotype. The SNP numbers correspond to those given in [Table 2](#pone.0117102.t002){ref-type="table"}.](pone.0117102.g001){#pone.0117102.g001}
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###### Nominally significant association results for SNPs in *DDR2* with BMD and fractures.
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  No.[^a^](#t003fn003){ref-type="table-fn"}   SNP             Physical position   Genic position   A1/A2[^b^](#t003fn004){ref-type="table-fn"}   Chinese BMD sample   Chinese fracture sample   Caucasian sample   *P* ~eQTL~ [^c^](#t003fn005){ref-type="table-fn"}                                            
  ------------------------------------------- --------------- ------------------- ---------------- --------------------------------------------- -------------------- ------------------------- ------------------ --------------------------------------------------- ------- ------- ------- -------- ------- -------
  **9**                                       **rs7521233**   162649471           Intron2          C/T                                           0.266                −0.018                    **1.06×10^−4^**    −                                                   −       −       0.233   0.002    0.307   −
  10                                          rs4657226       162653274           Intron2          G/A                                           0.388                −0.011                    0.015              0.399                                               0.395   0.337   0.259   0.001    0.502   0.043
  **11**                                      **rs6697469**   162658773           Intron2          C/G                                           0.253                −0.015                    **1.59×10^−3^**    0.266                                               0.245   0.043   0.092   0.005    0.169   0.896
  **12**                                      **rs7553831**   162661011           Intron2          T/G                                           0.264                −0.018                    **1.30×10^−4^**    0.273                                               0.264   0.058   0.229   0.003    0.251   0.322
  13                                          rs10737487      162667331           Intron2          G/A                                           0.407                −0.012                    6.86×10^−3^        0.429                                               0.403   0.153   0.259   0.002    0.436   0.016
  14                                          rs3923572       162671589           Intron2          T/C                                           0.237                −0.015                    2.27×10^−3^        0.251                                               0.234   0.192   0.069   0.003    0.107   0.918
  15                                          rs10917588      162676191           Intron2          C/T                                           0.398                −0.011                    9.31×10^−3^        0.420                                               0.384   0.050   0.096   0.003    0.328   0.277
  16                                          rs4559477       162681151           Intron2          T/G                                           0.365                −0.009                    0.032              0.378                                               0.362   0.205   0.105   0.003    0.484   0.392
  18                                          rs1039873       162692668           Intron3          C/G                                           0.226                −0.014                    5.72×10^−3^        0.241                                               0.226   0.217   0.080   0.005    0.209   0.889
  19                                          rs2805034       162699597           Intron3          A/G                                           0.229                −0.013                    9.91×10^−3^        −                                                   −       −       0.085   0.006    0.113   −
  20                                          rs1510310       162703160           Intron3          C/G                                           0.232                −0.012                    0.013              0.237                                               0.218   0.152   0.081   0.005    0.183   0.931
  21                                          rs2806423       162711989           Intron3          T/A                                           0.247                −0.012                    0.015              0.263                                               0.233   0.120   0.089   −0.003   0.416   0.931
  22                                          rs2684865       162721688           Intron3          T/C                                           0.222                −0.012                    0.014              −                                                   −       −       0.080   0.005    0.183   −
  23                                          rs2684866       162726281           Intron7          A/C                                           0.412                −0.009                    0.037              0.402                                               0.397   0.593   0.225   0.001    0.655   0.030
  25                                          rs2298258       162737116           Exon11           G/C                                           0.389                −0.009                    0.036              −                                                   −       −       0.146   −0.001   0.627   0.949
  26                                          rs3738807       162741794           Intron12         T/C                                           0.227                −0.015                    3.40×10^−3^        0.251                                               0.227   0.144   0.052   −0.007   0.139   0.921
  27                                          rs1780007       162748025           Intron16         A/C                                           0.420                −0.010                    0.020              0.427                                               0.427   0.846   0.206   0.001    0.751   0.416
  28                                          rs1779999       162753092           3'UTR            C/T                                           0.418                −0.011                    0.013              −                                                   −       −       −       −        −       0.614

Note: MAF, minor allele frequency; OR, odds ratio; CI, confidence interval. "−"means the *P* value was not available for this SNP.

Significant *P* values after multiple testing adjustment (*P* \< 0.0018) are shown in bold.

^a^ The IDs of SNPs correspond to [Table 2](#pone.0117102.t002){ref-type="table"}.

^b^A1 represents the minor allele.

^c^ *P* ~eQTL~ is shown for 45 HapMap Chinese Han individuals.

10.1371/journal.pone.0117102.t004

###### Haplotype analysis in the Chinese BMD sample.
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  Block     SNPs[^a^](#t004fn001){ref-type="table-fn"}   Haplotype[^b^](#t004fn002){ref-type="table-fn"}   Frequency   *P*-value         β
  --------- -------------------------------------------- ------------------------------------------------- ----------- ----------------- --------
  Block 1   2--8                                         AGTAAGA                                           0.361       0.164             0.006
                                                         AGTAAAA                                           0.255       0.667             0.002
                                                         AATAAGA                                           0.218       4.59×10^−3^       −0.014
                                                         GACGGGG                                           0.102       0.076             0.012
  Block 2   9--12                                        TAGG                                              0.615       0.014             0.011
                                                         **CGCT**                                          0.247       **9.54×10^−4^**   −0.016
                                                         TGGG                                              0.117       0.124             0.010
  Block 3   13--17                                       ACTGA                                             0.578       4.22×10^−3^       0.012
                                                         GTCTA                                             0.218       6.12×10^−3^       −0.014
                                                         GCCTG                                             0.127       0.617             0.003
  Block 4   18--28                                       GGGACCCCCCT                                       0.573       0.021             0.010
                                                         **CACTTACGTAC**                                   0.213       **2.63×10^−3^**   −0.015
                                                         GGGACATGCAC                                       0.133       0.489             0.004

^a^ The IDs of SNPs correspond to [Table 2](#pone.0117102.t002){ref-type="table"}.

^b^ For each block, we only listed the results of haplotypes with estimated frequencies more than 0.05.

Significant *P* values after multiple testing adjustment (*P* \< 0.0038) are shown in bold.

Association of the BMD associated SNPs in *DDR2* with fracture in the Chinese sample {#sec009}
------------------------------------------------------------------------------------

We also examined associations between fracture and the above 18 SNPs associated with BMD ([Table 3](#pone.0117102.t003){ref-type="table"}). SNP rs6697469 was found to be associated with hip fractures (*P* = 0.043), and the odds ratio (OR) was estimated to be 1.42 (95% confidence interval (CI): 1.04--1.95). Subjects with the heterozygote genotype CG had an increased risk of fracture, in comparison with those bearing GG genotype. Besides rs6697469, there were 2 additional SNPs showed marginally significant association signals with hip fractures, which were rs10917588 (*P* = 0.050) and rs7553831 (*P* = 0.058). These 2 SNPs also associated with increased risk of fractures, and the ORs were estimated to be 1.42 (95% CI: 1.02--1.97, genotypes CT versus TT at rs10917588), and 1.33 (95% CI: 0.97--1.81, genotypes TG versus GG at rs7553831), respectively. The effects on fracture risk for these 3 SNPs were totally consistent with their associations with lower BMD values.

Replication in the white samples {#sec010}
--------------------------------

We further checked the association results for the above 18 SNPs in our Caucasian sample ([Table 3](#pone.0117102.t003){ref-type="table"}). However, we didn't observe significant association signals between the above SNPs and hip BMD.

eQTL analysis results {#sec011}
---------------------

To investigate the functional relevance of the identified SNPs associated with BMD in *DDR2*, we performed eQTL analysis in Chinese and white samples from HapMap data, respectively. Three SNPs were significantly associated with *DDR2* mRNA expression levels in LCLs of 45 Chinese individuals ([Table 3](#pone.0117102.t003){ref-type="table"}). However, no significant association was found in 60 white individuals (data not shown).

Discussion {#sec012}
==========

Previous studies have established the important role of *DDR2* in regulating osteoblast differentiation and chondrocyte maturation \[[@pone.0117102.ref011],[@pone.0117102.ref016]\]. Deletions of *DDR2* in mice and humans have been found to be associated with dwarfism and short limbs \[[@pone.0117102.ref013],[@pone.0117102.ref014],[@pone.0117102.ref015]\]. Motivated by the functional role of *DDR2* involved in bone, we first performed an association study to investigate whether the common variants in *DDR2* influence BMD and fracture risk. We identified a cluster of SNPs in *DDR2* significantly associated with hip BMD and fractures in Chinese populations. The effects of *DDR2* on BMD and fracture were totally consistent. Taking into account of those biological evidence and our statistical findings, we suggest that *DDR2* might have potential role in BMD regulation and fracture pathogenesis.

To further evaluate the functional role of the identified SNPs in *DDR2*, we exploited eQTL analysis in human LCLs. Generally, analysis of *cis*-eQTL in tissue type relevant to phenotype is more informative than that in unrelated tissues. However, disease-related human tissues with large sample size are usually difficult to obtain for research purposes. Recent studies have shown that *cis*-eQTLs are conserved across tissues, and that tissue specific genetic variations comprise only a small proportion of gene expression diversity \[[@pone.0117102.ref025],[@pone.0117102.ref026],[@pone.0117102.ref027]\]. As for bone tissue, there is a large overlap in the transcriptomic effects of genetic variation between human osteoblasts and LCLs \[[@pone.0117102.ref028],[@pone.0117102.ref029]\], suggesting that if genes are expressed across tissues, their allele-specific expression can be preserved and highly correlated across tissues. Therefore, we examined *cis*-eQTL associations to ascertain whether the SNPs associated with BMD affected expression of *DDR2* in human LCLs using public HapMap data. We found that the SNPs associated with BMD also affected the expression of *DDR2* in the Chinese individuals, but not in the white individuals, suggesting that the eQTLs we identified might be ethnic specific. Additionally, although the top 3 significant SNPs associated with BMD were not the significant eQTLs, another SNP, rs4657226, which was in high LD with these 3 SNPs and belonged to one block, was significantly associated with *DDR2* expression levels. The sample size of HapMap data is relatively small. Limited power could influence the detection of additional associations. Nevertheless, our results confirm the relevance of the association data and provide supplementary insights that are indirectly informative for osteoporosis.

Most of BMD associated loci are reported in white populations. Genes predisposing to the risk of osteoporosis may vary between white and Asian populations \[[@pone.0117102.ref030]\]. Our study found significant association for *DDR2* with hip BMD and fractures in Chinese populations. However, the significant associations were not replicated in our Caucasian population. Such results implied an ethnic differentiation. The minor allele of SNP rs6697469 was much common in Chinese than Caucasians, which may contribute to the overall effect and in part explain the ethnic difference. Conversely rs7521233 and rs7553831 showed similar MAF in both ethnic groups. The LD patterns for these 3 SNPs were differ between Chinese (pairwise LD *r* ^2^ \> 0.9) and Caucasian (*r* ^2^ \< 0.6) samples, which could also explain the different results partly. Nevertheless, our findings support that it is interesting and valuable to conduct genetic susceptibility studies in Asian populations, which could expand our knowledge of the genetic basis of osteoporosis.

We estimated the statistical power of our study using the Genetic Power Calculator program (http://pngu.mgh.harvard.edu/\~purcell/gpc/qtlassoc.html). The conservative significance level was set at *P* = 0.0018. Assuming that a marker has a MAF of 0.05 and is in strong LD (*D'* = 0.98) with a functional variant that accounts for 1.0% variation of a phenotype, our Chinese BMD sample can achieve \> 65% statistical power. For the 3 significant SNPs we identified, the proportion of BMD variation explained by each SNP was 1.15% (rs7521233), 1.15% (rs7553831), and 0.81% (rs6697469), respectively. We acknowledge that our study is not powerful to detect genetic variants with low effect size.

In summary, our study provides novel evidence that *DDR2* is associated with hip BMD and fractures in Chinese populations. Considering the biological function of *DDR2*, we suggest that *DDR2* could be a new candidate in determining the risk of osteoporosis and fractures. Our results also reveal some extent of ethnic difference for *DDR2*, which highlight the need for further genetic studies in each ethnic group. Our findings further advance our understanding of the genetic architecture of osteoporosis. Whether DDR2 could be exploited as a novel therapeutic agent for osteoporosis warrants further investigation.
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